EMA
approval
· 2019-03-01
First treatment for rare disease characterised by high levels of triglycerides in blood
Summary
The EMA announces the first treatment for a rare disease characterized by very high triglyceride levels in the blood, addressing a previously unmet medical need…
Upgrade for the full analysis, importance score, and drug timeline.